Navigation Links
Achieve in Biological Technology

Quantros ACE Helps East Jefferson General Hospital Achieve Best-in-Class Performance

New Case Study Details Productivity Gains, Process Improvements Realized with Quantros Accreditation and Compliance Excellence Solution San Francisco, CA (PRWEB) July 21, 2009 -- Quantros, a leading provider of safety and quality software and professional services solut...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

Price reductions for liquid culture tests will accelerate access to improved TB diagnostics SEATTLE, June 17 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company; NYSE: BDX ), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss f...

LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting

Several of LASIK and refractive eye surgery experts listed at Trusted LASIK Surgeons were among those eye doctors honored at the recent American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Francisco, California. Dr. Parag Majmudar, Dr. Shachar Tauber, and Dr. William...

Gold-palladium nanoparticles achieve greener, smarter production of hydrogen peroxide

Hydrogen peroxide is one of the world's most versatile and widely used chemicals. A powerful oxidizing agent, H 2 O 2 is commonly used as a bleach, an antiseptic and a disinfectant. Despite its importance, however, says Christopher J. Kiely, hydrogen peroxide has eluded the best efforts of the...

Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report

Greatest ROI Opportunity for Consumers in Shortest Period of Time WASHINGTON, Jan. 27 /PRNewswire/ -- As the new administration examines the potential investment in targeted therapies that utilize personalized medicine to improve patient care, a new report released today by the Deloitte Cente...

Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process

MONTREAL, Oct. 22 /PRNewswire/ -- Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry announced today that 15 of the top 20 pharmaceutical companies have selected Global Vision to help them reduce the risk of textual and artwork errors from occurring in...

Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements

BERKELEY HEIGHTS, N.J., March 27 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced that the NASDAQ Listing Qualifications Panel has granted the Company's request for an extension of time to achieve full compliance with the applicable NASDAQ listing requirements. Pursuant ...

Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency

CHESTNUT HILL/CAMBRIDGE, Mass., March 20, 2008 - Researchers at Boston College and MIT have used nanotechnology to achieve a major increase in thermoelectric efficiency, a milestone that paves the way for a new generation of products from semiconductors and air conditioners to car exhaust systems...

Novavax Reports Second Quarter 2009 Financial Results

...ntly sponsored by ROVI and the Spanish authorities, will be formed and funded to support Phase III clinical development and other studies necessary to achieve market authorization of the VLP-based influenza vaccines in the European Union, which is targeted for 2012. Raised $21.9 million from the sale ...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...oduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2010 and 2010. A more complete description of these and other risks that could cause actual events to differ ...

ThermoGenesis Provides Update on Fiscal 2009 Results

... business and our new products--the MXP and Res-Q--we will be positioned to achieve meaningful growth in revenues during 2010," Engle added. "We expect to end...d result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2010 and 2010. Revenue and loss are...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...rical change in percent predicted FVC. While CAPACITY 1 did not achieve statistical significance on the primary endpoint at Week 72, the results we...linical experience with pirfenidone in IPF patients. Pirfenidone failed to achieve statistical significance on the primary endpoint in one of its two pivotal ...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... product candidates to prove safe and effective for treatment of non-small cell lung cancer, ovarian cancer, non-Hodgkin's lymphoma, and sarcoma or to achieve market acceptance for such treatments, the possibility that priority review will not be granted by the FDA for the pixantrone NDA and that a decision ...

The Breast Cancer Therapeutics Market in Australia

...ies for growth. About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with...

New clues about a hydrogen fuel catalyst

...gen fuel system that stores hydrogen safely and discharges hydrogen easily, which can then be used in fuel cells or other applications. One way to achieve such a fuel system is by "storing" hydrogen as part of a larger molecule. The molecule that contains hydrogen atoms, in this case ammonia borane, serv...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

...Study, which was performed at the request of the FDA. We believe that with this updated review timeline, if we gain approval in November, we may still achieve our overall goal of launching Qutenza in the United States in the first half of 2010." Conference Call Details The Company will hold i...

NxStage Reports Second Quarter 2009 Financial Results

...nge of $42 to $47 million or ($0.90) to ($1.01) per share, and for an Adjusted EBITDA loss in the range of $13 to $18 million. The Company expects to achieve consolidated gross margins of between 27 percent to 32 percent in the fourth quarter of 2009. For the third quarter of 2009, the Company is f...

New angle on gecko research

...ances place a premium on grip over outright speed," says Russell. In the case of the geckos, the intricate way that the toes are used in order to achieve the grip necessary to climb is responsible for slowing them. Russell and Higham are both evolutionary biologists and study animals in their natur...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

...lopment, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results o...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

...nsplant centers in the United States and France. Although orBec(R) did not achieve statistical significance in the primary endpoint of its pivotal trial, name...ian time-to-treatment failure through Day 50 (p-value 0.1177), orBec(R) did achieve statistical significance in other key secondary endpoints such as the propo...

SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS

...ng statements. Such statements include, but are not limited to, statements regarding: Senomyx's rights to the remaining license fee and our ability to achieve the specified events for receiving such payment; Senomyx's ability to discover and develop novel flavor ingredients for use as sweet enhancers of sucr...

Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores

... sales of our product will increase as the farmers have the opportunity to directly experience the dramatic impact on crop yields and quality they can achieve from applying our product." Each distributor sources successful, independently owned stores within their assigned territories that have typical...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...id dosing through use of Intermezzo ((R)); and the ability of Transcept to achieve its goal of becoming a fully integrated specialty pharmaceutical company. Transcept may not actually achieve the plans, intentions or expectations disclosed in our forward-looking stat...

Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients

...tients will continue to receive SOC. Patients who achieve undetectable levels of virus at weeks 4 and 12 wil...ility for patients in the ANA598 Phase II study to achieve undetectable levels of virus at weeks 4 and 12 and to achieve SVR; (iii) Anadys' expectation that it will receiv...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

...or 48. The primary endpoint of the study is the proportion of patients who achieve undetectable levels of virus at week 12 ( c omplete E arly V irological ...ciated with the reduction in force and facilities move; (vi) the ability to achieve EVR, RVR and SVR in the Phase II study; (vii) the expectation to begin pati...

PDI Appoints Gerald P. Belle as Lead Independent Director

...s in an ever-changing environment. As such, I look forward to working with PDI management and my fellow board members who remain committed to helping achieve the Company's growth goals while maintaining the highest standards of corporate governance," stated Mr. Belle. From 2004 until his retirement i...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... be between $2.59 and $2.67. The company now believes that it is likely to achieve the upper end of the adjusted diluted earnings per share guidance range. W...based on preliminary estimates and there can be no assurance that Endo will achieve these results. Includes all completed business development transactio...

Caliper Life Sciences Reports Second Quarter 2009 Results

...pro forma revenue. In addition, the Company reaffirmed its expectation to achieve positive earnings before interest, taxes, depreciation, amortization and st...s and its ability to attain cash flow breakeven performance, its ability to achieve positive earnings before interest, taxes, depreciation, amortization and st...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

...ommercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products...

Sanofi-aventis Announces Second Quarter 2009 Results

...urring cost savings(6) in 2013 relative to 2008. These savings will be achieved across all Group functions. Our aim is therefore to achieve at least the same level of sales in 2013 vs. 2008 before any significant external growth opportunities. Key growth drivers (Vaccines, Diabetes product...

Breaking barriers with nanoscale lasers

...worked only in a low-temperature operating environment. The next step is to achieve the same laser light emission at room temperature. Researchers worldwide...says. "We discovered we were working on the same problems and trying to achieve similar goals using similar ideas," he says. "So the partnership developed....

Cynosure Reports Second Quarter 2009 Financial Results

...ompared with first six months of 2008, largely through the cost-reduction efforts we put in place early this year," Davin said. "We remain on track to achieve our previously stated goal of annualized operating expense savings of between $14 million and $18 million in 2009. We were cash flow neutral in the s...

PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug

...ns of human growth hormone, erythropoietin, interferon beta, GLP-1, and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

...long-acting versions of human growth hormone, erythropoietin, interferon beta or GLP-1; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications ...

Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

...ut Frost & Sullivan - "We Accelerate Growth" Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with...

Free Webinar on Safer Clinical Hand-Offs Offered by Compirion Healthcare

...c Imaging, Materials Management, Inpatient, Outpatient and Nursing Care improvement projects. Compirion contracts only for measurable outcomes to help achieve patient satisfaction, staff loyalty and a better bottom line. For more information on Compirion's sustainable healthcare solutions, call 1-86...

MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients

...nical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products) , its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, inc...

QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy

...ndomised into MoxDuo(TM) IV or morphine IV groups over a two-part, 48-hour treatment period. In Part 1, rapid dosing will be used by the physician to achieve maximal reductions in pain. In Part 2, patients will manage their own pain relief on an "as needed" basis using self-administered PCA (patient control...

Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer

...S. diagnostic business, developing strategic investment and action plans to achieve U.S. market leadership for key Roche business platforms, directing efforts ... strategy for high value technologies were aligned with the market needs to achieve peak product sales faster. "This is one of the more exciting tec...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

...ing market conditions. We continued to invest in new products, in sales and marketing initiatives and in facilities that are expected to enable us to achieve above-market rate organic sales growth. And we plan to continue to drive process improvements through our supply chain initiative and manage costs pru...
Other Tags
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
(Date:7/27/2014)... can evade treatment by acquiring mutations in the genes ... were once thought to be the only way for ... shown that microorganisms can use a temporary silencing of ... the benefits of drug resistance without the commitment. , ... called Mucor circinelloides, it is likely to be employed ...
(Date:7/27/2014)... patients, scientists have identified more than two dozen ... six that had not been previously reported. The ... partially funded by the National Institutes of Health ... laboratories. , "Unraveling the genetic underpinnings of Parkinson,s ... in this complex disease, and hopefully, may one ...
Breaking Biology News(10 mins):Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
(Date:7/29/2014)... July 29, 2014 Tucson-based company ... employer’s benefits package, or health and wellness program, called ... while providing an effective way for employees to use ... of the program, employees specify the amount of each ... , An employer benefits from offering a 401(play)™ plan ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, ... new sleep experience. The top of each luxurious resort bed ... , These expertly crafted, 100% Egyptian cotton white duvets and ... yet upon closer look, words are woven in the linens ... breathe. , Intentional breathing and visualization are keys ...
(Date:7/29/2014)... 2014 In his latest blog post at ... CEO Per Wickstrom has listed 6 ways to light the ... creativity and avoid complacency, but for some it’s a losing ... progressive and powerful ways to help employees get to the ... as a whole.” , According to Per Wickstrom, 6 ways ...
(Date:7/29/2014)... Battle Creek, MI (PRWEB) July 29, 2014 ... treatment program that gets clients off to a great start ... believe in, was a proud sponsor of the National Cherry ... City, MI. , The concert, which was co-sponsored by Miller ... Collective Soul take to the Pepsi Bay Side Music Stage ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
Other Contents